Adenosine analogue-type A3 receptor agonists having an N6 nitrogen substituted by a group which is usually —CH
2
-CYCLE, where CYCLE is a specified heteroaromatic group, particularly a pyrridyl or a bicyclic group, for example benzoxazole. Preferred CYCLE moieties are substituted in specified positions by, in particular, halo or methyl and, at another position, a dialkylamine.
具有N6氮原子被替换为通常为-
CH2-CYCLE的基团的
腺苷类A3受体激动剂,其中CYCLE是一个特定的杂环芳香基团,特别是
吡啶基或双环基团,例如苯并
噁唑。首选的CYCLE基团在特定位置被卤素或甲基取代,并且在另一个位置上具有二烷基胺。